drugset / Trial / NCT03530631

Neuroimaging the Expectancy Versus Pharmacotherapy Effect of Adderall on Cognitive Performance

NCT03530631 ↗

Phase 4 Completed 4 enrolled University of Alabama at Birmingham
RandomizedFactorialDouble-blindHealth-services research

Summary

The purpose of this balanced-placebo design study is to pilot a larger study to further explore the current evidence that stimulant medications are not cognitive enhancers, despite this rampant belief in young adults. While the lack of cognitive enhancement from stimulant medication has been documented in prior research, this study is the first to utilize neuroimaging technology to examine brain regions activated during neurocognitive tasks when participants believe they have been administered stimulant medication or placebo.

Timeline

Start
2018-11-10
Primary completion
2018-12-18
Completion
2018-12-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Adderall Unknown — —

Indications

No indication recorded.